Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Systemic immunosuppression in limbal stem cell transplantation: best practices and future challenges.

Ballios BG, Weisbrod M, Chan CC, Borovik A, Schiff JR, Tinckam KJ, Humar A, Kim SJ, Cole EH, Slomovic AR.

Can J Ophthalmol. 2018 Aug;53(4):314-323. doi: 10.1016/j.jcjo.2017.10.040. Epub 2018 Jan 20. Review.

PMID:
30119783
2.

Reciprocity to Increase Participation of Compatible Living Donor and Recipient Pairs in Kidney Paired Donation.

Gill JS, Tinckam K, Fortin MC, Rose C, Shick-Makaroff K, Young K, Lesage J, Cole EH, Toews M, Landsberg DN, Gill J.

Am J Transplant. 2017 Jul;17(7):1723-1728. doi: 10.1111/ajt.14275. Epub 2017 Apr 22.

3.

The Canadian kidney paired donation program: a national program to increase living donor transplantation.

Cole EH, Nickerson P, Campbell P, Yetzer K, Lahaie N, Zaltzman J, Gill JS.

Transplantation. 2015 May;99(5):985-90. doi: 10.1097/TP.0000000000000455.

PMID:
25340607
4.

Hypercalcemia in renal transplant patients: prevalence and management in Canadian transplant practice.

Muirhead N, Zaltman JS, Gill JS, Churchill DN, Poulin-Costello M, Mann V, Cole EH.

Clin Transplant. 2014 Feb;28(2):161-5. doi: 10.1111/ctr.12291. Epub 2013 Dec 13.

PMID:
24329899
5.

Financial incentives to increase Canadian organ donation: quick fix or fallacy?

Gill JS, Klarenbach S, Barnieh L, Caulfield T, Knoll G, Levin A, Cole EH.

Am J Kidney Dis. 2014 Jan;63(1):133-40. doi: 10.1053/j.ajkd.2013.08.029. Epub 2013 Nov 5.

PMID:
24200461
6.

A pilot study of reduced dose cyclosporine and corticosteroids to reduce new onset diabetes mellitus and acute rejection in kidney transplant recipients.

Cole EH, Prasad GV, Cardella CJ, Kim JS, Tinckam KJ, Cattran DC, Schiff JR, Landsberg DN, Zaltzman JS, Gill JS.

Transplant Res. 2013 Jan 12;2(1):1. doi: 10.1186/2047-1440-2-1.

7.

Kidney function and risk of cardiovascular disease and mortality in kidney transplant recipients: the FAVORIT trial.

Weiner DE, Carpenter MA, Levey AS, Ivanova A, Cole EH, Hunsicker L, Kasiske BL, Kim SJ, Kusek JW, Bostom AG.

Am J Transplant. 2012 Sep;12(9):2437-45. doi: 10.1111/j.1600-6143.2012.04101.x. Epub 2012 May 17.

8.

Living donor age and kidney allograft half-life: implications for living donor paired exchange programs.

Chang P, Gill J, Dong J, Rose C, Yan H, Landsberg D, Cole EH, Gill JS.

Clin J Am Soc Nephrol. 2012 May;7(5):835-41. doi: 10.2215/CJN.09990911. Epub 2012 Mar 22.

9.

Comparison of hospitalized solid organ transplant recipients and nonimmunocompromised patients with pandemic H1N1 infection: a retrospective cohort study.

Minnema BJ, Patel M, Rotstein C, Mazzulli T, Hota S, Cole EH, Renner EL, Ross HJ, Singer LG, Husain S.

Transplantation. 2011 Jul 27;92(2):230-4. doi: 10.1097/TP.0b013e3182200e5c.

PMID:
21577178
10.

Delayed graft function and the risk of death with graft function in living donor kidney transplant recipients.

Narayanan R, Cardella CJ, Cattran DC, Cole EH, Tinckam KJ, Schiff J, Kim SJ.

Am J Kidney Dis. 2010 Nov;56(5):961-70. doi: 10.1053/j.ajkd.2010.06.024. Epub 2010 Sep 25.

PMID:
20870331
11.

Policy statement of Canadian Society of Transplantation and Canadian Society of Nephrology on organ trafficking and transplant tourism.

Gill JS, Goldberg A, Prasad GV, Fortin MC, Hansen TB, Levin A, Gill J, Tonelli M, Tibbles LA, Knoll G, Cole EH, Caulfield T.

Transplantation. 2010 Oct 27;90(8):817-20. doi: 10.1097/TP.0b013e3181efd030. No abstract available.

PMID:
20697329
12.

Delayed graft function and the risk for death with a functioning graft.

Tapiawala SN, Tinckam KJ, Cardella CJ, Schiff J, Cattran DC, Cole EH, Kim SJ.

J Am Soc Nephrol. 2010 Jan;21(1):153-61. doi: 10.1681/ASN.2009040412. Epub 2009 Oct 29.

13.

Impact of deceased donor diabetes mellitus on kidney transplant outcomes: a propensity score-matched study.

Ahmad M, Cole EH, Cardella CJ, Cattran DC, Schiff J, Tinckam KJ, Kim SJ.

Transplantation. 2009 Jul 27;88(2):251-60. doi: 10.1097/TP.0b013e3181ac68a9.

PMID:
19623022
14.

Renal transplantation with early steroid withdrawal.

Schiff J, Cole EH.

Pediatr Nephrol. 2009 Feb;24(2):243-51. doi: 10.1007/s00467-008-0876-0. Epub 2008 Jun 6. Review.

PMID:
18535842
15.

Transplant recipient's knowledge of posttransplant malignancy risk: implications for educational programs.

Kauffman HM, Woodle ES, Cole EH, Paykin C; National Kidney Foundation.

Transplantation. 2008 Apr 15;85(7):928-33. doi: 10.1097/TP.0b013e31816a105b. No abstract available.

PMID:
18408569
16.

Impact of acute rejection and new-onset diabetes on long-term transplant graft and patient survival.

Cole EH, Johnston O, Rose CL, Gill JS.

Clin J Am Soc Nephrol. 2008 May;3(3):814-21. doi: 10.2215/CJN.04681107. Epub 2008 Mar 5.

17.

A comparison of the effects of C2-cyclosporine and C0-tacrolimus on renal function and cardiovascular risk factors in kidney transplant recipients.

Kim SJ, Prasad GV, Huang M, Nash MM, Famure O, Park J, Thenganatt MA, Chowdhury N, Cole EH, Fenton SS, Cattran DC, Zaltzman JS, Cardella CJ.

Transplantation. 2006 Oct 15;82(7):924-30.

PMID:
17038908
18.

Reduced incidence of new-onset diabetes mellitus after renal transplantation with 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors (statins).

Prasad GV, Kim SJ, Huang M, Nash MM, Zaltzman JS, Fenton SS, Cattran DC, Cole EH, Cardella CJ.

Am J Transplant. 2004 Nov;4(11):1897-903.

19.

Neoral C2 monitoring in maintenance liver transplant patients: a step forward?

Levy GA, Cole EH.

Liver Transpl. 2004 Feb;10(2):190-2. Review. No abstract available.

20.

Angiotensinogen M235T genotype predicts progression in chronic renal allograft dysfunction.

Prasad GV, Pinnaduwage D, Parkes RK, Midgley J, Balfe JW, Hegele RA, Bull SB, Cole EH, Logan AG.

Transplantation. 2003 Jan 27;75(2):209-16.

PMID:
12548125
21.

Kidney transplantation in the elderly: a decision analysis.

Jassal SV, Krahn MD, Naglie G, Zaltzman JS, Roscoe JM, Cole EH, Redelmeier DA.

J Am Soc Nephrol. 2003 Jan;14(1):187-96.

22.

Improvement in rejection of human decay accelerating factor transgenic pig-to-primate renal xenografts with administration of rabbit antithymocyte serum.

Ghanekar A, Lajoie G, Luo Y, Yang H, Choi J, Garcia B, Cole EH, Greig PD, Cattral MS, Phillips MJ, Cardella CJ, Levy GA, Zhong R, Grant DR.

Transplantation. 2002 Jul 15;74(1):28-35.

PMID:
12134095
23.

Kinetic analysis of a unique direct prothrombinase, fgl2, and identification of a serine residue critical for the prothrombinase activity.

Chan CW, Chan MW, Liu M, Fung L, Cole EH, Leibowitz JL, Marsden PA, Clark DA, Levy GA.

J Immunol. 2002 May 15;168(10):5170-7.

24.

Treatment with rabbit antithymocyte serum permits a cyclophosphamide-free approach to prevention of hDAF transgenic porcine kidney xenograft rejection in baboons.

Ghanekar A, Lajoie G, Luo Y, Yang H, Choi J, Garcia B, Greig PD, Cattral MS, Cole EH, Phillips MJ, Cardella CJ, Levy GA, Zhong R, Grant DR.

Transplant Proc. 2001 Nov-Dec;33(7-8):3849-50. No abstract available.

PMID:
11750638
25.

Neoral monitoring: limitations of trough level monitoring and the potential role of limited sampling strategies.

Cole EH.

Transplant Proc. 2000 Nov;32(7):1556-8. Review. No abstract available.

PMID:
11119832
26.

Allograft de novo membranous nephropathy complicating Alport's syndrome.

Prasad GV, Sweet JM, Cole EH, Cardella CJ.

Nephron. 2000 Oct;86(2):227. No abstract available.

PMID:
11015013
27.

Catecholamines and transplantation.

Geddes CC, Prasad GV, Agarwal L, Reich H, Wei C, Cole EH.

Kidney Int. 2000 Mar;57(3):1206-7. No abstract available.

28.

Outcome in recipients of dual kidney transplants: an analysis of the dual registry patients.

Lu AD, Carter JT, Weinstein RJ, Stratta RJ, Taylor RJ, Bowers VD, Ratner LE, Chavin KD, Johnson LB, Kuo PC, Cole EH, Dafoe DC, Alfrey EJ.

Transplantation. 2000 Jan 27;69(2):281-5.

PMID:
10670639
29.

Early experience with dual kidney transplantation in adults using expanded donor criteria. Double Kidney Transplant Group (DKG).

Remuzzi G, GrinyĆ² J, Ruggenenti P, Beatini M, Cole EH, Milford EL, Brenner BM.

J Am Soc Nephrol. 1999 Dec;10(12):2591-8.

30.

Identification of a unique glomerular factor X activator in murine lupus nephritis.

Perampalam S, Wang L, Myers-Mason N, Yeow JN, Stanietsky N, Phillips J, Weitz JI, Ackerley C, Levy GA, Cole EH.

J Am Soc Nephrol. 1999 Nov;10(11):2332-41.

31.

Clinical practice guidelines: prevention of cytomegalovirus disease after renal transplantation.

Jassal SV, Roscoe JM, Zaltzman JS, Mazzulli T, Krajden M, Gadawski M, Cattran DC, Cardella CJ, Albert SE, Cole EH.

J Am Soc Nephrol. 1998 Sep;9(9):1697-708. Review.

32.

Strategies to prevent thrombosis in xenotransplants.

Levy GA, Marsden P, Zhong R, Cole EH, Grant D.

Transplant Proc. 1998 Aug;30(5):2458-60. Review.

PMID:
9723536
33.

Renal transplantation in Canada.

Cole EH.

Nephrol News Issues. 1998 May;12(5):38-40. No abstract available.

PMID:
9644458
34.

Fulminant hepatic failure in murine hepatitis virus strain 3 infection: tissue-specific expression of a novel fgl2 prothrombinase.

Ding JW, Ning Q, Liu MF, Lai A, Leibowitz J, Peltekian KM, Cole EH, Fung LS, Holloway C, Marsden PA, Yeger H, Phillips MJ, Levy GA.

J Virol. 1997 Dec;71(12):9223-30. Erratum in: J Virol 1998 Apr;72(4):3504.

35.

Modulation of renal prostaglandin metabolism in therapy of lupus nephritis.

Cole EH.

J Rheumatol. 1996 Oct;23(10):1686-8. No abstract available.

PMID:
8895140
36.
37.

Outcomes of percutaneous kidney biopsy, including those of solitary native kidneys.

Mendelssohn DC, Cole EH.

Am J Kidney Dis. 1995 Oct;26(4):580-5. Review.

PMID:
7573010
38.

Characterization of the procoagulant-inducing factor derived from the plasma of BXSB mice.

Cole EH, Neil G, Myers-Mason N, Fung LS, Levy GA.

J Autoimmun. 1995 Feb;8(1):47-59.

PMID:
7734036
39.
40.

A comparison of rabbit antithymocyte serum and OKT3 as prophylaxis against renal allograft rejection.

Cole EH, Cattran DC, Farewell VT, Aprile M, Bear RA, Pei YP, Fenton SS, Tober JA, Cardella CJ.

Transplantation. 1994 Jan;57(1):60-7.

PMID:
8291115
42.

Effect of eicosanoids on induction of procoagulant activity by murine hepatitis virus strain 3 in vitro.

Chung SW, Sinclair SB, Fung LS, Cole EH, Levy GA.

Prostaglandins. 1991 Dec;42(6):501-13.

PMID:
1666190
43.

Monoclonal antibody analysis of a unique macrophage procoagulant activity induced by murine hepatitis virus strain 3 infection.

Fung LS, Neil G, Leibowitz J, Cole EH, Chung S, Crow A, Levy GA.

J Biol Chem. 1991 Jan 25;266(3):1789-95.

44.

Ancrod improves survival in murine systemic lupus erythematosus.

Cole EH, Glynn MF, Laskin CA, Sweet J, Mason N, Levy GA.

Kidney Int. 1990 Jan;37(1):29-35.

45.

Dissociation between the immunosuppressive activity of cyclosporine derivatives and their effects on intracellular calcium signaling in mesangial cells.

Goldberg HJ, Wong PY, Cole EH, Levy GA, Skorecki KL.

Transplantation. 1989 Apr;47(4):731-3. No abstract available.

PMID:
2705211
46.

Proteinuria in renal transplant recipients: incidence, cause, prognostic importance.

Bear RA, Aprile M, Sweet J, Cole EH.

Transplant Proc. 1988 Dec;20(6):1235-6. No abstract available.

PMID:
3059611
47.

Early function as the principal correlate of graft survival. A multivariate analysis of 200 cadaveric renal transplants treated with a protocol incorporating antilymphocyte globulin and cyclosporine.

Halloran PF, Aprile MA, Farewell V, Ludwin D, Smith EK, Tsai SY, Bear RA, Cole EH, Fenton SS, Cattran DC.

Transplantation. 1988 Aug;46(2):223-8.

PMID:
3043779
48.

Cyclosporin A metabolites suppress T-cell proliferation by concanavalin A and in a mixed lymphocyte reaction.

Abecassis M, Wong PY, Mason N, Cheung F, Mee AV, Cole EH, Langer B, Cohen Z, Levy GA.

Can J Surg. 1988 May;31(3):145-50.

PMID:
2966666
49.

Identification of cyclosporine metabolites in human bile, blood, and urine by high-performance liquid chromatography/radioimmunoassay/fast atomic bombardment mass spectroscopy.

Cheung F, Wong PY, Loo J, Cole EH, Levy GA.

Transplant Proc. 1988 Apr;20(2 Suppl 2):602-8. No abstract available.

PMID:
3284109
50.

Cyclosporine metabolites suppress T cell proliferation induced by concanavalin A.

Dindzans VJ, Wong PY, Mee AV, Cheung F, Abecassis M, Cole EH, Cohen Z, Levy GA.

Transplant Proc. 1987 Aug;19(4):3490-3. No abstract available.

PMID:
3303521

Supplemental Content

Support Center